Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 360 results:
Author Title Type [ Year] Filters: Author is Polyzos, Stergios A [Clear All Filters]
Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations..
Maturitas. 147, 19-25.
(2021). Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders..
Metabolism. 154736.
(2021). A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension..
Liver Int.
(2021). Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations..
Aliment Pharmacol Ther.
(2021). Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021). Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease..
Eur J Pharmacol. 907, 174272.
(2021). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis..
Neurochem Int. 144, 104938.
(2021). Ιrisin levels in postmenopausal women with an incident hip fracture..
Endocrine. 73(3), 719-722.
(2021). Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients..
J Clin Med. 9(4),
(2020). Alzheimer's disease and gastrointestinal microbiota; impact of infection involvement..
Int J Neurosci. 1-13.
(2020). Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis..
Microorganisms. 8(6),
(2020). Combination and sequential treatment in women with postmenopausal osteoporosis..
Expert Opin Pharmacother. 21(4), 477-490.
(2020). Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name..
Metabolism. 113, 154413.
(2020). Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus..
Diabetes Metab Syndr. 14(6), 1913-1919.
(2020). Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis..
Metabolism. 154203.
(2020). Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity..
Hepatobiliary Surg Nutr. 9(1), 73-76.
(2020). Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis..
Ann Hepatol. 19(5), 579-580.
(2020). Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'..
Carcinogenesis.
(2020). Helicobacter pylori infection as a potential risk factor for multiple sclerosis..
Med Hypotheses. 143, 110135.
(2020). Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?.
Obes Surg.
(2020). Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited..
J Gastrointestin Liver Dis. 29(2), 270-271.
(2020).
(2020). Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease..
Aliment Pharmacol Ther. 51(2), 313-314.
(2020). Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma..
Aliment Pharmacol Ther. 51(11), 1215-1216.
(2020).
(2020).